SCHEMBL3388733

SCHEMBL3388733

NC(=O)c1ccc(-c2ccc(Nc3nc4ccc(F)cc4s3)c(F)c2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 3/20 0.67
MAPT P10636 9/20 0.55
SMN1; SMN2 Q16637 7/20 0.55
MEN1 O00255 6/20 0.55
KMT2A Q03164 6/20 0.55
KDM4E B2RXH2 6/20 0.55
HTT P42858 6/20 0.55
HPGD P15428 5/20 0.55
LMNA P02545 5/20 0.55
GAA P10253 3/20 0.55
MCL1 Q07820 3/20 0.55
TNF P01375 2/20 0.55
NOD1 Q9Y239 2/20 0.55
NR2F2 P24468 1/20 0.55
KLF5 Q13887 1/20 0.55
CSGALNACT1 Q8TDX6 1/20 0.53
NPC1 O15118 7/20 0.51
ALDH1A1 P00352 7/20 0.51
RAB9A P51151 6/20 0.51
ALPL P05186 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1761436 0.90 DGAT1 (0.71) DGAT1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL3388727 0.89 DGAT1 (0.67) DGAT1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL3387754 0.88 DGAT1 (0.66) DGAT1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1761400 0.87 MAPT (0.71) DGAT1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1761458 0.83 DGAT1 (0.63) DGAT1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1761485 0.82 DGAT1 (0.66) DGAT1MAPTSMN1; SMN2MEN1KMT2A
Bicarbonate SCHEMBL2311510 0.82 DGAT1 (0.77) DGAT1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL1761392 0.82 DGAT1 (0.62) DGAT1MAPTSMN1; SMN2MEN1KMT2A
Bicarbonate SCHEMBL3386226 0.82 DGAT1 (0.69) DGAT1MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL13249174 0.82 DGAT1 (0.59) DGAT1MAPTSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805156-B1 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER HEALTHCARE LLC (US) 2010-12-22 EP claimed
EP-1805156-A4 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORP (US) 2009-06-10 EP claimed
EP-1805156-A2 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY Bayer Pharmaceuticals Corporation (US) 2007-07-11 EP claimed
WO-2006044775-A2 PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY BAYER PHARMACEUTICALS CORPORATION (US) 2006-04-27 WO claimed